ProKidney (PROK) Earnings Date, Estimates & Call Transcripts $1.67 -0.16 (-8.74%) As of 02:46 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ProKidney Latest Earnings SummaryActual EPS (Nov. 12) -$0.14 Consensus EPS (Nov. 12) -$0.14 ProKidney released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.14, which met analysts' consensus estimates of -$0.14. With a trailing EPS of -$0.55, ProKidney's earnings are expected to grow next year, from ($0.57) to ($0.33) per share. Get ProKidney Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ProKidney and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPROK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PROK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ProKidney Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.57) EPSNext Year EPS Consensus Estimate: ($0.33) EPS ProKidney Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024--$0.14-$0.14--$0.14--8/9/2024--$0.17-$0.16+$0.01-$0.16--5/10/2024Q1 2024-$0.25-$0.16+$0.09-$0.16--3/21/2024Q4 2023-$0.19-$0.09+$0.10-$0.09--11/14/2023Q3 2023-$0.16-$0.18 -$0.02-$0.18--8/10/2023Q2 2023-$0.41-$0.14+$0.27-$0.14-- Get the Latest News and Ratings for PROK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProKidney and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023--$0.16 -$0.16-$0.16--3/28/2023Q4 2022-$0.24-$0.11+$0.13-$0.11-- ProKidney Earnings - Frequently Asked Questions When did ProKidney announce their last quarterly earnings? ProKidney (NASDAQ:PROK) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on PROK's earnings history. Did ProKidney beat their earnings estimates last quarter? In the previous quarter, ProKidney (NASDAQ:PROK) reported ($0.14) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.14). Learn more on analysts' earnings estimate vs. PROK's actual earnings. How much profit does ProKidney generate each year? ProKidney (NASDAQ:PROK) has a recorded net income of -$35.47 million. PROK has generated -$0.55 earnings per share over the last four quarters. What is ProKidney's EPS forecast for next year? ProKidney's earnings are expected to grow from ($0.57) per share to ($0.33) per share in the next year. More Earnings Resources from MarketBeat Related Companies MIRM Earnings Results WVE Earnings Results HRMY Earnings Results AKRO Earnings Results IBRX Earnings Results AGIO Earnings Results GLPG Earnings Results IRON Earnings Results ARQT Earnings Results AMPH Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles S&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough 70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << This page (NASDAQ:PROK) was last updated on 1/8/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDonald Trump to Repeal Executive Order #14110?Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this Stock before Trump Takes Office!We're issuing an urgent "buy alert" on a little-known "AI company" set to SOAR under this new administration. ...Behind the Markets | SponsoredMy #1 Crypto of 2025 – “Crypto Royalties”Man Who Recommended Bitcoin at $600 – Reveals: “Crypto Royalties” My #1 Crypto Play for 2025 and Beyond… It...Centurion Publishing | SponsoredThey deceived America for decades. Not anymoreIn my new film, The Texas Conspiracy, I’ll tell you all about these three men – who they are, where they come ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
